Expertise in
11
conditions

Takaki Yoshikawa

Tokyo, JP 
Expertise in
11
conditions
Tokyo, JP 

Overview

Takaki Yoshikawa practices practicing medicine in Tokyo, Japan.

Yoshikawa is highly rated in 11 conditions, according to our data. Their clinical expertise encompasses Stomach Cancer, Gastroesophageal Junction Cancer, Esophageal Cancer, Gastrectomy, and Splenectomy.

They are actively involved in clinical research, co-authoring 433 peer reviewed articles and participating in 1 clinical trial.

Locations

Tokyo, Japan
Other Locations
Yokohama, Japan
Chuo, 1040045, Japan
Chuo, Japan
Tsukiji, Japan
Tsukiji, 1040045, Japan
Kashiwa, 2778577, Japan
Osaka, Japan
Japan
Kanagawa, Japan
Minato, Japan
Musashimurayama, Japan
Saitama, Japan
Tokorozawa, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug, Other
Study Phase: Phase 3

433 Total Publications

Primary outcomes of a phase II trial of laparoscopic/robotic total gastrectomy with spleen-preserving splenic hilar dissection for locally advanced proximal gastric cancer involving the greater curvature (JCOG1809).
Primary outcomes of a phase II trial of laparoscopic/robotic total gastrectomy with spleen-preserving splenic hilar dissection for locally advanced proximal gastric cancer involving the greater curvature (JCOG1809).
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: July 01, 2026

Frequently Asked Questions about Takaki Yoshikawa

Is Takaki Yoshikawa a top-rated expert for Stomach Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Takaki Yoshikawa is classified as an Elite expert for Stomach Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Takaki Yoshikawa participate in research or clinical trials?

Yes. Takaki Yoshikawa has published 433 articles and abstracts on conditions like Stomach Cancer. You can view a list of Takaki Yoshikawa's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yoshikawa's expertise for a condition
ConditionClose
View All 37 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile